Kindeva Drug Delivery LP

General

Total Cases3

Active Cases1

Patents2

CourtsN.D. West Virginia

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
03/08/23	Astrazeneca Ab v. Mylan Pharma Inc 1:18-CV-00193 ( N.D. WV )	ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023) ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/08/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	AMENDED CLERK'S JUDGMENT: Judgment is entered in favor of plaintiffs against defendants. This case has been STRICKEN from the active docket of the Court. Signed by Clerk of Court, Cheryl Dean Riley, on 3/08/2023. (hrc) (Entered: 03/08/2023)
03/08/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	STIPULATED MODIFIED AMENDED FINAL JUDGMENT ORDER. Clerk is DIRECTED to enter judgment in favor of plaintiffs and against defendants. Ordered that the Amended Final Judgment Order is vacated to [ECF No. 240 ]. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/08/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	RED LINE VERSION OF STIPULATED MODIFIED AMENDED FINAL JUDGMENT ORDER. Clerk is DIRECTED to enter judgment in favor of plaintiffs and against defendants. Ordered that the Amended Final Judgment Order is vacated to [ECF No. 240 ]. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/07/23	Astrazeneca Ab v. Mylan Pharma Inc 1:18-CV-00193 ( N.D. WV )	MANDATE of USCA for the Federal Circuit as to 608 Notice of Appeal filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (dk) (Entered: 03/07/2023)
03/07/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	MANDATE of USCA for the Federal Circuit as to 238 Notice of Appeal filed by Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (dk) (Entered: 03/07/2023)
03/06/23	Astrazeneca Ab v. Mylan Pharma Inc 1:18-CV-00193 ( N.D. WV )	ORDER GRANTING INDICATIVE RULING. ORDERED that if the cases are remanded to this Court by the Court of Appeals for the Federal Circuit, this Court will grant a joint motion pursuant to Rule 60(b)(5) and (6) of the Federal Rules of Civil Procedure, will (1) vacate the Amended Final Judgment Order (ECF No. 240) in the 558 Patent Action; (2) enter the Stipulated Modified Amended Final Judgment Order (Ex. 2) in the 558 Patent Action; and (3) enter the Order Vacating Rulings and Dismissing Case (Ex. 3) in the 247 Patent Action. Signed by District Judge John Preston Bailey on 3/06/2023. (hrc) (Entered: 03/06/2023) ORDER GRANTING INDICATIVE RULING. ORDERED that if the cases are remanded to this Court by the Court of Appeals for the Federal Circuit, this Court will grant a joint motion pursuant to Rule 60(b)(5) and (6) of the Federal Rules of Civil Procedure, will (1) vacate the Amended Final Judgment Order (ECF No. 240) in the 558 Patent Action; (2) enter the Stipulated Modified Amended Final Judgment Order (Ex. 2) in the 558 Patent Action; and (3) enter the Order Vacating Rulings and Dismissing Case (Ex. 3) in the 247 Patent Action. Signed by District Judge John Preston Bailey on 3/06/2023. (hrc) (Entered: 03/06/2023)
03/06/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	ORDER GRANTING MOTION FOR EXTENSION OF TIME. Court Orders that Plaintiffs shall have through and until July 29, 2023. Signed by District Judge John Preston Bailey on 3/6/2023. (hrc) (Entered: 03/06/2023)
03/06/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	ORDER GRANTING INDICATIVE RULING. ORDERED that if the cases are remanded to this Court by the Court of Appeals for the Federal Circuit, this Court will grant a joint motion pursuant to Rule 60(b)(5) and (6) of the Federal Rules of Civil Procedure, will (1) vacate the Amended Final Judgment Order (ECF No. 240 ) in the 558 Patent Action; (2) enter the Stipulated Modified Amended Final Judgment Order (Ex. 2) in the 558 Patent Action; and (3) enter the Order Vacating Rulings and Dismissing Case (Ex. 3) in the 247 Patent Action. Signed by District Judge John Preston Bailey on 3/6/2023. (hrc) (Entered: 03/06/2023) ORDER GRANTING INDICATIVE RULING. ORDERED that if the cases are remanded to this Court by the Court of Appeals for the Federal Circuit, this Court will grant a joint motion pursuant to Rule 60(b)(5) and (6) of the Federal Rules of Civil Procedure, will (1) vacate the Amended Final Judgment Order (ECF No. 240 ) in the 558 Patent Action; (2) enter the Stipulated Modified Amended Final Judgment Order (Ex. 2) in the 558 Patent Action; and (3) enter the Order Vacating Rulings and Dismissing Case (Ex. 3) in the 247 Patent Action. Signed by District Judge John Preston Bailey on 3/6/2023. (hrc) (Entered: 03/06/2023)
03/03/23	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	MOTION for Extension of Time to File Bill of Costs by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Attachments: # 1 Proposed Order Extending Time to File Briefs on Bill of Costs)(Law, Sandra) (Entered: 03/03/2023)